Expertise in
7
conditions

Rob S. Van Binnendijk

Bilthoven, UT, NL 
Expertise in
7
conditions
Bilthoven, UT, NL 
OverviewLocationsClinical Research

Overview

Rob Van Binnendijk practices in Bilthoven, Netherlands. Mr. Van Binnendijk is highly rated in 7 conditions, according to our data. His top areas of expertise are Mumps, Parainfluenza, Measles, Orchitis, and Kidney Transplant.

His clinical research consists of co-authoring 80 peer reviewed articles. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Bilthoven, UT, Netherlands
Other Locations
Netherlands
Utrecht, UT, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

80 Total Publications

What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health Organization.
What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health Organization.
Journal: Vaccine
Published: January 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Van Binnendijk's expertise for a condition
ConditionClose
View All 10 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile